SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India flag India · Delayed Price · Currency is INR
356.60
+0.10 (0.03%)
Aug 21, 2026, 3:29 PM IST

SMS Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,020691.36498.26-70.59622.2
Depreciation & Amortization
399.19342.16314.67320.72320.93
Other Amortization
2.212.682.052.22.51
Loss (Gain) From Sale of Assets
--0.21-0.370.54-0.02
Loss (Gain) From Sale of Investments
-5.469.752.252.011.56
Other Operating Activities
116.27202.13229.88282.5287.18
Change in Accounts Receivable
-126.33330-878.47-998.27571.61
Change in Inventory
-664.77-510.31-101.98275.98-1,133
Change in Accounts Payable
65.17-374.06438.68424.3774.18
Change in Income Taxes
-8.3115.3443.0632.91-14.58
Change in Other Net Operating Assets
-205.62108.26-46.77-47.89-81.85
Operating Cash Flow
592.24817.09501.25224.5450.6
Operating Cash Flow Growth
-27.52%63.01%123.27%-50.18%-50.19%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,306-1,234-521.6-299.21-272.47
Sale of Property, Plant & Equipment
-0.560.882.630.17
Investment in Securities
--0.15-0.07-1.68-
Other Investing Activities
-2.22-0.90.070.690.77
Investing Cash Flow
-1,308-1,234-520.72-297.56-271.53

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
261.05108.03202.07258.778.89
Long-Term Debt Issued
623.19637.24450.8694.14451.9
Total Debt Issued
884.24745.27652.93352.91460.79
Short-Term Debt Repaid
-----38.35
Long-Term Debt Repaid
-343.52-447.99-388.01-437.93-337.45
Total Debt Repaid
-343.52-447.99-388.01-437.93-375.8
Net Debt Issued (Repaid)
540.72297.28264.92-85.0284.99
Common Dividends Paid
-35.46-33.86-25.4-25.4-25.4
Other Financing Activities
255.09207.3767.26-209.28-177.06
Financing Cash Flow
760.35470.79306.79-319.69-117.47

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0---
Net Cash Flow
44.7853.6287.32-392.7561.6

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-713.35-416.71-20.35-74.71178.12
Free Cash Flow Growth
-----
Free Cash Flow Margin
-8.04%-5.32%-0.29%-1.43%3.43%
Free Cash Flow Per Share
-7.80-4.70-0.24-0.882.10
Levered Free Cash Flow
-951.08-694.83-252.73-316-224.79
Unlevered Free Cash Flow
-809.07-587.33-112.92-186.46-113.22

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
221.12173.53217.52209.28177.06
Cash Income Tax Paid
241198.3315446149.2
Change in Working Capital
-939.86-430.78-545.48-312.89-583.75